Technical Analysis for FULC - Fulcrum Therapeutics, Inc.

Grade Last Price % Change Price Change
C 10.12 -10.92% -1.24
FULC closed down 10.92 percent on Monday, March 18, 2024, on 1.35 times normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
NR7 Range Contraction -10.92%
NR7-2 Range Contraction -10.92%
Narrow Range Bar Range Contraction -10.92%
Inside Day Range Contraction -10.92%
Calm After Storm Range Contraction -9.48%
NR7 Range Contraction -9.48%
Wide Bands Range Expansion -9.48%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 9 hours ago
Down 10% about 12 hours ago
Down 5% about 13 hours ago
Fell Below 20 DMA about 13 hours ago
Down 1 ATR about 13 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Disease Disability Disorders Dystrophy Muscular Dystrophy Hemoglobin Progressive Infancy Sickle Cell Disease Thalassemia Facioscapulohumeral Muscular Dystrophy

Is FULC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.7
52 Week Low 2.25
Average Volume 683,733
200-Day Moving Average 5.44
50-Day Moving Average 8.92
20-Day Moving Average 10.63
10-Day Moving Average 11.16
Average True Range 0.87
RSI (14) 49.49
ADX 54.94
+DI 29.43
-DI 19.82
Chandelier Exit (Long, 3 ATRs) 11.08
Chandelier Exit (Short, 3 ATRs) 11.70
Upper Bollinger Bands 12.13
Lower Bollinger Band 9.12
Percent B (%b) 0.33
BandWidth 28.39
MACD Line 0.64
MACD Signal Line 0.79
MACD Histogram -0.1484
Fundamentals Value
Market Cap 625.64 Million
Num Shares 61.8 Million
EPS -1.66
Price-to-Earnings (P/E) Ratio -6.10
Price-to-Sales 208.91
Price-to-Book 2.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.36
Resistance 3 (R3) 12.56 12.02 11.98
Resistance 2 (R2) 12.02 11.45 11.92 11.86
Resistance 1 (R1) 11.07 11.10 10.80 10.87 11.73
Pivot Point 10.53 10.53 10.40 10.43 10.53
Support 1 (S1) 9.58 9.96 9.31 9.38 8.51
Support 2 (S2) 9.04 9.61 8.94 8.38
Support 3 (S3) 8.09 9.04 8.26
Support 4 (S4) 7.89